Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Vifor-Pharma
Company Monitoring Page for Vifor-Pharma
latest headlines for company on cafepharma
Vifor Pharma offers to fix alleged anti-competitive behaviour
Reuters
Fri, 04/19/24 - 11:24 am
Tags:
Vifor Pharma
,
antitrust
,
anti-competitive scheme
CSL gets top-line boost thanks to a post-pandemic boom in plasma collections
Fierce Pharma
Wed, 08/16/23 - 11:14 pm
Tags:
CSL
,
COVID-19
,
plasma
,
CSL Behring
,
Vifor Pharma
Days after buyout news, Vifor outlines plan to offload 'non-core' finished drug manufacturing wing
Endpoints
Thu, 12/16/21 - 11:53 pm
Tags:
Vifor Pharma
,
CSL
,
M&A
Biopharma’s buyout year ends with a bang
EP Vantage
Wed, 12/15/21 - 10:37 am
Tags:
M&A
,
CSL
,
Vifor Pharma
,
Pfizer
,
Arena Pharmaceuticals
As year-end deals start to sizzle, CSL moves a biotech buyout to the front burner with deal expected Tuesday — report
Endpoints
Mon, 12/13/21 - 11:02 am
Tags:
M&A
,
Vifor Pharma
,
CSL
Sanifit, having put Spain's biotech scene on the map, lands $231M Vifor buyout ahead of phase 3 data
Fierce Biotech
Mon, 11/22/21 - 10:23 am
Tags:
Spain
,
Sanifit
,
M&A
,
Vifor Pharma
Angion’s kidney transplant dream dies
EP Vantage
Wed, 10/27/21 - 10:52 am
Tags:
Angion Biomedica
,
ANG-3777
,
kidney injury
,
Vifor Pharma
Vifor Licenses Rare Kidney Disease Drug in Comeback for Travere
BioSpace
Sat, 09/18/21 - 08:23 pm
Tags:
Vifor Pharma
,
Travere Therapeutics
,
kidney disease
FDA Action Alert: Cara/Vifor, Kadmon, BMS, Merck/Eisai
BioSpace
Mon, 08/23/21 - 11:10 am
Tags:
FDA
,
Cara Therapeutics
,
Vifor Pharma
,
Korsuva
,
Kadmon
,
belumosudil
,
Bristol Myers Squibb
,
Opdivo
,
Merck
,
Eisai
,
Keytruda
Vifor Pharma Group announces successful sale of OM Pharma
Pharmaceutical Business Review
Mon, 09/21/20 - 10:29 am
Tags:
Vifor Pharma
,
OM Pharma
,
Optimus Holding
,
M&A
Vifor commits €25M to nephrology R&D joint venture with Evotec
Fierce Biotech
Wed, 11/6/19 - 10:30 am
Tags:
Vifor Pharma
,
Evotec
,
renal therapy
,
nephrology
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.